Fra­zier re­loads with $1.4B to bet on 'growth buy­out' plays — near­ly dou­ble the last fund

5 years ago
Financing

Eye in­jec­tions caus­ing blind­ness? FDA’s stem cell clin­ic crack­down read­ies for ac­tion

5 years ago
FDA+

FDA ad­comm votes in fa­vor of ap­prov­ing Proven­tion Bio’s drug to de­lay type 1 di­a­betes

5 years ago
Pharma
FDA+

CD­MO Ter­gus cuts the rib­bon on Durham plant, lat­est in a line of com­pa­nies pack­ing in­to the emerg­ing NC hub

5 years ago
Manufacturing

Bio­gen adds key man­u­fac­tur­ing plant to its po­ten­tial­ly quixot­ic ad­u­canum­ab launch plan

5 years ago
Manufacturing

Q&A: Amid an M&A flur­ry at Charles Riv­er, long­time ex­ec Bir­git Gir­shick dis­cuss­es how Covid-19 has changed the game

5 years ago
People
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: WHO let­ter out­lines re­boot of IP shar­ing pro­gram; In­dia backs down on ...

5 years ago
Coronavirus
Manufacturing

Astel­las out­lines an­oth­er five-year plan; Bay­er's VC arm leaps in­to dig­i­tal health

5 years ago
News Briefing

Eli Lil­ly's much-ma­ligned Branch­burg plant earns a fed­er­al sub­poe­na amid whistle­blow­er claims tied to Covid-19 work

5 years ago
Coronavirus
Manufacturing

Ma­gen­ta's R&D head hits the ex­it just weeks af­ter read­ing out mid-stage da­ta for lead ther­a­py, eye­ing clin­ic for ...

5 years ago
People

El­liott is back­ing away from a threat­ened ac­tivist at­tack on Glax­o­SmithK­line, giv­ing CEO Em­ma Walm­s­ley some breath­ing ...

5 years ago
Pharma

Alise Re­icin re­cruits GNF vet Pe­ter Mc­Na­ma­ra to head re­search at Tim Springer's lat­est start­up

5 years ago
People
R&D

FDA adds new 'do not use' note to In­ter­cep­t's Ocali­va la­bel af­ter a slew of side ef­fect re­ports in cir­rho­sis pa­tients

5 years ago
FDA+

FDA steers J&J/Leg­end CAR-T to a quick de­ci­sion as part­ners prep a loom­ing show­down with Bris­tol My­ers, blue­bird

5 years ago
Cell/Gene Tx
FDA+

Look­ing to build new smart cells, Blue­Rock teams with Tim Lu's Sen­ti Bio in 'sec­ond-or­der' en­gi­neer­ing al­liance

5 years ago
Deals
Cell/Gene Tx

US paus­es use of Eli Lil­ly Covid-19 mAb com­bo in six more states due to vari­ants from Brazil, In­dia

5 years ago
Pharma
Coronavirus

Five an­a­lyt­ics firms launch RWE lob­by­ing group to press Con­gress, FDA on guid­ance, Cures 2.0

5 years ago
FDA+

Covid-19 roundup: Pres­i­dent Biden or­ders in­tel­li­gence com­mu­ni­ty to re­dou­ble ef­forts to de­ter­mine if virus orig­i­nat­ed ...

5 years ago
Coronavirus

As FDA clears re­l­u­golix for uter­ine fi­broids, My­ovant, Pfiz­er gear up to take on Ab­b­Vie in com­mer­cial ri­val­ry

5 years ago
Pharma
FDA+

No­vo Hold­ings, Vi­vo lead a record $200M raise for a Sin­ga­pore-based tools play­er with plans for a Boston hub, new ...

5 years ago
Financing
China

A UK an­ti­fun­gal play­er with a Big Phar­ma pedi­gree bags fresh round of cash as it races to­ward late-stage tri­al

5 years ago
Financing

FDA au­tho­rizes Vir-GSK an­ti­body as vari­ants threat­en Eli Lil­ly mAb

5 years ago
R&D
Coronavirus

Mer­ck KGaA draws the cur­tain on newest lipid nanopar­ti­cle for mR­NA vac­cines, tur­bocharg­ing its an­nu­al ca­pac­i­ty

5 years ago
Coronavirus
Manufacturing

Opin­ion: It shouldn’t mat­ter who the FDA com­mis­sion­er is when it comes to con­tro­ver­sial drug ap­proval de­ci­sions

5 years ago
FDA+
Opinion
First page Previous page 697698699700701702703 Next page Last page
A service from the Financial Times